Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Atezolizumab and Nab-paclitaxel

Department of Health and Social Care written question – answered on 10th February 2020.

Alert me about debates like this

Photo of Sharon Hodgson Sharon Hodgson Shadow Minister (Public Health)

To ask the Secretary of State for Health and Social Care, what meetings representatives of (a) NICE and (b) NHS England have had with Roche on atezolizumab with nab-paclitaxel for breast cancer patients since the publication of NICE's draft guidance on that drug in October 2019.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

NHS England and NHS Improvement has advised that it has met with Roche to discuss potential commercial arrangements for atezolizumab with nab-paclitaxel for breast cancer patients.

The National Institute for Health and Care Excellence (NICE) has advised that it held a telephone call with Roche on 23 January 2020 regarding atezolizumab with nab-paclitaxel for breast cancer patients and that it has been in contact with Roche by email since the publication of NICE's draft guidance in October 2019.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.